Inderjit Singh, MD
Urology · Woodbridge, VANPI 1396897617
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,179 of the $14,178 with a category attached, or 78.8%. Procept Biorobotics Corporation accounts for 94.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2023 at $5,570 and has fallen 95.5% since, to $252 in 2025.
Across 50 payments — averaging $283.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$13K
- Calyxo, Inc.$177
- Olympus America Inc.$121
- Bayer$94
- Johnson & Johnson$46
- Pfizer$44
- plus $304 from 10 others
What the payments were for
- Consulting fees$11,17979%
- Travel & lodging$1,78113%
- Food & beverage$1,1888%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 26 | $13,391 |
| Calyxo, Inc. | 2 | $177 |
| Olympus America Inc. | 5 | $121 |
| Bayer | 1 | $94 |
| Johnson & Johnson | 2 | $46 |
| Pfizer | 3 | $44 |
| Endo Pharmaceuticals Inc. | 1 | $43 |
| Teleflex LLC | 1 | $42 |
| Sun Pharmaceutical Industries Inc. | 1 | $42 |
| Rochester Medical Corporation | 2 | $36 |
| AbbVie | 1 | $33 |
| Merck | 1 | $31 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Urogen Pharma, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $18 |
| Therapeuticsmd, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$12,709
- CVAC Aspiration System$148
- AQUABEAM SYSTEM$124
How this compares
$14,178 in reported general payments places this provider in the 80th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 33 | $30,146 |
| Trospium Chloride | 89 | $8,603 |
| Tamsulosin Hcl | 502 | $5,644 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 109 | $2,551 |
| Oxybutynin Chloride ErOxybutynin Chloride | 55 | $1,908 |
| Silodosin | 12 | $1,112 |
| Solifenacin Succinate | 27 | $981 |
| Finasteride | 67 | $842 |
| Methenamine Hippurate | 11 | $412 |
| Dutasteride | 13 | $371 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $257 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 63 | $179 |
| CefuroximeCefuroxime Axetil | 11 | $149 |
| Ciprofloxacin Hcl | 29 | $130 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other urology in Woodbridge
- Nilay GandhiWoodbridge$138K
- Shawn MarhamatiWoodbridge$130K
- Pratik DesaiWoodbridge$13K
- Michael FabrizioVirginia Beach$1.5M
- Gregg EureVirginia Beach$1.4M
- Jessica DelongVirginia Beach$578K
- Robert GivenVirginia Beach$157K
- Michael WilliamsVirginia Beach$144K
- Patrick WhelanSuffolk$114K
- Jennifer Miles-ThomasVa Beach$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.